UnitedHealth Says Trump's 2027 Medicare Rates 'Profoundly Negative' For Seniors

Core Viewpoint - UnitedHealth Group, Inc. experienced a significant stock decline of 20% in one day due to disappointing fourth-quarter earnings and a low 2027 rate proposal from the Centers for Medicare & Medicaid Services (CMS) [1][2]. CMS Rate Shock - The CMS 2027 Advance Notice proposed a net payment increase of only 0.09%, a stark contrast to analyst expectations of 4% to 6%, effectively acting as a budget cut in the context of medical inflation running between 7% and 10% [3]. - UnitedHealthcare Unit CEO Timothy Noel criticized the CMS notice for failing to reflect the realities of medical utilization and cost trends, emphasizing the need for a more appropriate final growth rate calculation [4]. Financial & Operational Strain - CEO Stephen Hemsley highlighted that the CMS rate proposal would lead to significant benefit reductions across the industry, impacting seniors' choices, access, and affordability [6]. - The stock performance of health insurers was broadly negative, with CVS Health Corp. and Humana, Inc. also experiencing declines of 14% and 19%, respectively [7]. - UnitedHealth's Medical Care Ratio (MCR) approached 90%, indicating that nearly 90 cents of every dollar in premiums is spent on medical claims, driven by high utilization in behavioral health and specialty drugs [7]. - GAAP earnings for the fourth quarter plummeted nearly 100% to just one cent per share, primarily due to restructuring charges and ongoing costs from a cyberattack [7]. - The company anticipates losing up to 1.4 million Medicare Advantage members in 2026 as it shifts focus from growth to profit margins [7].